Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Harold Elliot Varmus (nacido el 18 de diciembre de 1939) es un científico estadounidense ganador del premio Nobel, fue el decimocuarto director del Instituto Nacional del Cáncer, puesto para el cual fue nombrado por el presidente Barack Obama, [1] y antes de eso fue director de los Institutos Nacionales de Salud de 1993 a 1999. [2]

    • Constance Louise Casey (cas. 1969; 2 hijos)
    • Nueva York
    • Estadounidense
  2. Harold Eliot Varmus (born December 18, 1939) is an American Nobel Prize -winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center .

    • Cancer biology
  3. Harold Elliot Varmus. (Oceanside, 1939) Médico e investigador estadounidense, premio Nobel de Fisiología y Medicina de 1989 por el descubrimiento del origen celular de los oncogenes retrovirales. Su primera inclinación cultural fue la literatura; realizó estudios literarios en la Universidad de Harvard, pero pronto tomó interés por la ...

  4. 12 de abr. de 2024 · Harold Varmus, American virologist and cowinner (with J. Michael Bishop) of the Nobel Prize for Physiology or Medicine in 1989 for his work on the origins of cancer. He later served as president (2000–10) of Memorial Sloan Kettering Cancer Center in New York City.

    • The Editors of Encyclopaedia Britannica
  5. 22 de oct. de 2015 · Dr. Harold E. Varmus was nominated to become the 14th director of NIH by President William J. Clinton and was sworn in by HHS Secretary Donna Shalala on November 23, 1993. Winner of the Nobel Prize in 1989 for his work in cancer research (and the first Nobel Laureate to lead the NIH), his appointment was also notable for his lack of ...

  6. Biographical Overview. For over three decades, Harold Varmus has advanced fundamental scientific knowledge at the intersection of virology, oncology, and genetics, both as a researcher and as a science administrator.

  7. Harold Varmus. We recently described our initial efforts to develop a model for small cell lung cancer (SCLC) derived from human embryonic stem cells (hESCs) that were differentiated to form...